Enalapril Maleate Oral Solution Interactions

Brand names: Enalapril Maleate Oral Solution

FDA Black Box Warning

WARNING: FETAL TOXICITY When pregnancy is detected, discontinue enalapril maleate as soon as possible. [See Warnings and Precautions (5.1)] Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. [See Warnings and Precautions (5.1)] WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue Enalapril maleate as soon as possible. (5.1) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. (5.1)

1 interaction on record

Enalapril Maleate Oral Solution + EnalaprilModerate

(7.4) 7.1 Non-Steroidal Anti-Inflammatory Agents (NSAIDs) Including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including enalapril, may result in deterioration of renal function, including possible acute renal failure. Monitor renal function periodically in patients receiving enalapril and NSAID therapy. In a clinical pharmacology study, indomethacin or sulindac was administered to hypertensive patients receiving enalapril maleate.

Source: FDA drug label - enalapril maleate oral solution